Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
CELL GENESYS INC (CEGE) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/14/2009 8-K Quarterly results
09/21/2009 8-K Other Events
08/05/2009 8-K Form 8-K - Current report
06/30/2009 8-K Form 8-K -- Current report
06/29/2009 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Indenture, between Cell Genesys, Inc. and U.S. Bank National Association, as trustee"
06/17/2009 8-K Regulation FD Disclosure
05/18/2009 8-K Form 8-K -- Current report
05/11/2009 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Settlement and Exchange Support Agreement, by and between Cell Genesys, Inc. and Tang Capital Partners, LP",
"Cell Genesys Announces Plans to Commence Exchange Offer for Its Outstanding 3.125% Convertible Notes and Settlement of Insolvency Litigation"
04/30/2009 8-K Quarterly results
Docs: "Cell Genesys Announces First Quarter 2009 Financial Results GVAX Development Terminated - Company Continues to Pursue Strategic Alternatives"
04/09/2009 8-K Form 8-K -- Current report
03/09/2009 8-K Quarterly results
Docs: "Cell Genesys Announces Fourth Quarter and Year-End 2008 Financial Results"
02/19/2009 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
12/09/2008 8-K Form 8-K -- Current report
11/06/2008 8-K Quarterly results
Docs: "Cell Genesys Reports Third Quarter 2008 Financial Results"
10/24/2008 8-K Form 8-K -- Current report
10/22/2008 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
Docs: "Cell Genesys Announces Receipt of Nasdaq Staff Deficiency Notice Relating to Non-Compliance with a Nasdaq Stock Market Listing Requirement"
10/16/2008 8-K Cost Associated with Exit or Disposal Activities, Departure of Directors or Principal Officers; Election of Directors; Appoin...
Docs: "Cell Genesys Announces Termination of VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer Based on Outcome of Futility Analysis and Reports Preliminary Analysis of VITAL-2 Trial Results"
09/11/2008 8-K Other Events, Financial Statements and Exhibits
Docs: "Cell Genesys Reconfirms Ongoing Plans with FDA for Phase 3 Program for GVAX Immunotherapy for Prostate Cancer While on Partial Clinical Hold"
08/27/2008 8-K Other Events, Financial Statements and Exhibits
Docs: "Cell Genesys Halts VITAL-2 GVAX Trial in Advanced Prostate Cancer"
08/01/2008 8-K Quarterly results
Docs: "Cell Genesys Reports Second Quarter 2008 Financial Results"
05/12/2008 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
05/01/2008 8-K Quarterly results
Docs: "Cell Genesys Reports First Quarter 2008 Financial Results"
03/31/2008 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
02/28/2008 8-K Quarterly results
Docs: "Cell Genesys Reports Fourth Quarter and Year-End 2007 Results"
01/15/2008 8-K Other Events, Financial Statements and Exhibits
12/20/2007 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
11/01/2007 8-K Quarterly results
Docs: "CELL GENESYS REPORTS THIRD QUARTER 2007 FINANCIAL RESULTS"
10/23/2007 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
Docs: "Amended and Restated Bylaws of Cell Genesys, Inc."
08/07/2007 8-K Quarterly results
Docs: "CELL GENESYS REPORTS SECOND QUARTER 2007 RESULTS"
08/01/2007 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers, Financial Statements ...
Docs: "Form of Restricted Stock Unit Award Agreement"
07/10/2007 8-K Other Events
Docs: "CELL GENESYS COMPLETES PATIENT RECRUITMENT FOR FIRST PHASE 3 CLINICAL TRIAL OF GVAX IMMUNOTHERAPY FOR PROSTATE CANCER"
05/10/2007 8-K Quarterly results
Docs: "CELL GENESYS REPORTS FIRST QUARTER 2007 RESULTS"
04/18/2007 8-K Other Events
Docs: "CELL GENESYS REPORTS GVAX IMMUNOTHERAPY FOR PROSTATE CANCER INDUCES A BROAD, PATIENT-SPECIFIC ANTIBODY RESPONSE"
04/11/2007 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Placement Agency Agreement by and between Cell Genesys and Credit Suisse Securities (USA) LLC, Needham & Company, LLC, Canaccord Adams Inc. and Cantor Fitzgerald & Co",
"Form of Warrant",
"Opinion of Wilson Sonsini Goodrich & Rosati, Professional Corporation",
"Form of Subscription Agreement, between the Company and the investor signatories thereto",
"CELL GENESYS ANNOUNCES REGISTERED DIRECT COMMON STOCK AND WARRANT OFFERING OF $60 MILLION"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy